EUVIMEDEUVIMED entdecken
Crossref

METTL3-mediated N6-methyladenosine modification of UHRF1 promotes osteosarcoma malignancy through silencing SFRP1 via DNA methylation

Kaishan Ye, Haiyu Zhou, Yulong Ma, Wenxiang Shen

Molecular Biology Reports · 2026-12 · 53 (1)

DOI: 10.1007/s11033-026-12882-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, online erschienen am 30.10.2026. Verfasst von Kaishan Ye und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Second Hospital of Lanzhou University, No. 82, Cuiyingmen, Chengguan District, Lanzhou, 730030, Gansu Province, China. ery…. Hauptthemen laut MEDLINE: Osteosarcoma, Membrane Proteins, DNA Methylation, Intercellular Signaling Peptides and Proteins. Die Arbeit nennt 65 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, the Excellent Young Talent Scientific Research Project of Health Industry in Gansu Province, the Cuiying Scientific and Technological Innovation Program of the Second Hospital & Clinical Medical School, Lanzhou University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Osteosarcoma (OS) ranks among the most frequently diagnosed primary malignant bone neoplasms. Secreted frizzled-related protein 1 (SFRP1) functions as a tumor suppressor across multiple cancer types. Nevertheless, the precise molecular mechanisms governing SFRP1 dysregulation in OS remain incompletely understood. This study aims to characterize the functional role of SFRP1 in OS malignancy and dissect the molecular mechanisms governing its regulation. METHODS AND RESULTS: The quantitative real-time polymerase chain reaction (qRT-PCR), enzyme-linked immunosorbent assay (ELISA) and western blotting assay showed that SFRP1 expression was significantly downregulated in human OS cells relative to normal osteoblasts. Lentivirus mediated overexpression of SFRP1 substantially inhibited the viability, proliferation, invasion, and epithelial-mesenchymal transition (EMT), as well as tumor growth in xenograft tumor model. A methylation-specific polymerase chain reaction (MSP) assay revealed pronounced hypermethylation of the SFRP1 promoter region in OS cells. Chromatin immunoprecipitation (ChIP) experiments further demonstrated that UHRF1 regulates SFRP1 expression through promoter methylation. The m6A modification level of UHRF1 was determined using methylated RNA immunoprecipitation (MeRIP). Notably, both the levels of m6A modification of UHRF1 and the expression of methyltransferase-like 3 (METTL3) were significantly elevated in human OS cells compared with normal osteoblasts. Knockdown of METTL3 significantly reduced the m6A levels of ubiquitin-like containing PHD and RING finger domains 1 (UHRF1) mRNA, accelerated UHRF1 mRNA decay, restored SFRP1 expression, and attenuated OS cell viability, proliferation, invasion, and EMT. CONCLUSION: METTL3-mediated m6A modification of UHRF1 drives OS malignancy via DNA methylation-dependent silencing of SFRP1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaMembrane ProteinsDNA MethylationIntercellular Signaling Peptides and ProteinsAdenosineMethyltransferasesUbiquitin-Protein LigasesCCAAT-Enhancer-Binding ProteinsBone NeoplasmsHumansSecreted Frizzled-Related ProteinsCell Line, TumorGene Expression Regulation, NeoplasticAnimalsCell ProliferationMicePromoter Regions, GeneticMice, NudeEpithelial-Mesenchymal Transition

Stichwörter der Autor:innen

METTL3OsteosarcomaSFRP1UHRF1m6A modification

Substanzen

SFRP1 protein, humanSecreted Frizzled-Related ProteinsMembrane ProteinsIntercellular Signaling Peptides and ProteinsAdenosineMethyltransferasesN-methyladenosineUbiquitin-Protein LigasesCCAAT-Enhancer-Binding ProteinsMETTL3 protein, human

Autor:innen und Institutionen

  • Department of Orthopedics, Second Hospital of Lanzhou University, No. 82, Cuiyingmen, Chengguan District, Lanzhou, 730030, Gansu Province, China. ery_yeksh@lzu.edu.cn.
  • Department of Orthopedics, Second Hospital of Lanzhou University, No. 82, Cuiyingmen, Chengguan District, Lanzhou, 730030, Gansu Province, China.

Förderung

  • the National Natural Science Foundation of China
  • the Excellent Young Talent Scientific Research Project of Health Industry in Gansu Province
  • the Cuiying Scientific and Technological Innovation Program of the Second Hospital & Clinical Medical School, Lanzhou University

Zitieren

APA

Ye, K., Zhou, H., Ma, Y., & Shen, W. (2026). METTL3-mediated N6-methyladenosine modification of UHRF1 promotes osteosarcoma malignancy through silencing SFRP1 via DNA methylation. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-12882-9

Vancouver

Ye K, Zhou H, Ma Y, Shen W. METTL3-mediated N6-methyladenosine modification of UHRF1 promotes osteosarcoma malignancy through silencing SFRP1 via DNA methylation. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-12882-9

BibTeX
@article{Ye2026,
  author = {Ye, Kaishan and Zhou, Haiyu and Ma, Yulong and Shen, Wenxiang},
  title = {METTL3-mediated N6-methyladenosine modification of UHRF1 promotes osteosarcoma malignancy through silencing SFRP1 via DNA methylation},
  journal = {Molecular Biology Reports},
  year = {2026},
  volume = {53},
  number = {1},
  doi = {10.1007/s11033-026-12882-9}
}
Kostenlos starten →